Form 4: Dellora Investments LP Ceases to be 10% Owner of Palvella Therapeutics Following Merger
Ownership Disclosure
Dellora Investments LP is no longer a 10% shareholder in Palvella Therapeutics following the completion of a merger and financing on December 13, 2024.
Summary
- Dellora Investments LP has filed a Form 4 indicating a change in their ownership status in Palvella Therapeutics, Inc.
- The change occurred after the closing of a merger and financing on December 13, 2024.
- As a result of this transaction, Dellora Investments LP is no longer considered a 10% owner of Palvella Therapeutics.
- The filing was signed by Kevin Pyun, Principal of Dellora Investments GP LLC, the General Partner of Dellora Investments LP, on December 16, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing indicating a change in ownership structure. It is neither positive nor negative in itself.
Industry Context
This filing reflects a change in ownership structure following a merger, which is a common occurrence in the biotechnology and pharmaceutical industries. It indicates a shift in the shareholder base of Palvella Therapeutics.
Stakeholder Impact
- The change in ownership may have a minor impact on the shareholder base of Palvella Therapeutics.
Key Dates
| Date | Description |
|---|---|
| 12/13/2024 | Date of the merger and financing that resulted in Dellora Investments LP no longer being a 10% owner. |
| 12/16/2024 | Date the Form 4 was signed and filed. |
Keywords
Palvella Therapeutics, Dellora Investments LP, Form 4, Merger, Ownership Change, Shareholder, Financing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.